Pulmonary heart: A review

Cover Page

Cite item

Full Text

Abstract

The review on the problem of the pulmonary heart pursues two goals: firstly, to restore historical justice and to show the priority studies of doctor Dmitry D. Pletnev on such problems as diagnosis of right ventricular myocardial infarction, clinical characteristics of congestive heart failure of the right ventricle; secondly, to outline the modern concept of the pulmonary heart. The review provides an analysis of the pathogenetic mechanisms of the development of heart failure in the pulmonary heart. Much attention is paid to echo cardiography data and biological markers are emphasized in assessing the function of the right atrium, right ventricle, tricuspid valve regurgitation, pulmonary artery pressure. Prognostically unfavorable signs of the course of the pulmonary heart have been identified, which include a high degree of tricuspid valve regurgitation, the amplitude of movement of the fibrous valve ring (TAPSE) and atrial fibrillation developing with dilation of the right atrium.

About the authors

Alexander G. Chuchalin

Pirogov Russian National Research Medical University

Author for correspondence.
Email: pulmomoskva@mail.ru
ORCID iD: 0000-0002-6808-5528

акад. РАН, доктор медицинских наук, профессор, зав. кафедрой госпитальной терапии педиатрического факультета, председатель правления Российского респираторного общества

Russian Federation, Moscow

References

  1. Плетнев Д.Д. Болезни сердца. М., 1936–2022 [Pletnev DD. Bolezni serdtsa. Moscow, 1936–2022 (in Russian)].
  2. Плетнев Д.Д. К вопросу о прижизненной дифференциальной диагностики тромбоза правой и левой венечных артерий сердца. Русская клиника. 1925 [Pletnev DD. K voprosu o prizhiznennoi differentsial'noi diagnostiki tromboza pravoi i levoi venechnykh arterii serdtsa. Russkaia klinika. 1925 (in Russian)].
  3. Коган Б.Б. Бронхиальная астма. М. 1959 [Kogan BB. Bronkhial'naia astma, Moscow. 1959 (in Russian)].
  4. Мухарлямов Н.М. Легочное сердце. М., 1973 [Mukharliamov NM. Legochnoie serdtse. Moscow, 1973 (in Russian)].
  5. Starr I, Jeffers WA, Meade RH Jr. The absence of conspicuous increments of venous pressure after severe damage to the right ventricle of the dog, with a discussion of the relation between clinical congestive failure and heart disease. Am Heart J. 1943;26:291-301.
  6. Obakata M, Reddy YNV, Melenovsky V, et al. Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction. Eur Heart J. 2019;40:68-697. doi: 10.1093/eurheartj/ehy809
  7. Hassoun PM. Pulmonary arterial hypertension. N Engl J Med. 2021;385:2361-76. doi: 10.1056/NEJMra2000348
  8. Corica B, Marra AM, Basili S. Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19. Sci Rep. 2021;11:17774. doi: 10.1038/s41598-021-96955-8
  9. Vonk Noordegraaf A, Westerhof BE, Westerhof N. The relationship between the right ventricle and its load in pulmonary hypertension. J Am Col Cardiol. 2017;69:236-43. doi: 10.1016/j.jacc.2016.10.047
  10. Rain S, Andersen S, Najafi F. Right ventricular myocardial stiffness in experimental pulmonary arterial hypertension: relative contribution of fibrosis and myofibril stiffness. Circ Heart Fail. 2016;9:e002636. doi: 10.1161/CIRCHEARTFAILURE.115.002636
  11. Widya RL, van der Meer RW, Smith JWA. Right ventricular involvement in diabetic cardiomyopathy. Diabetes Care. 2013;36:457-62. doi: 10.2337/dc12-0474
  12. Linssen PBC, Veugen MGJ, Henry RMA. Association of diabetes with right ventricular and atrial structure and function. Cardiovascul Diabetol. 2020;19:88. doi: 10.1186/s12933-020-01055-y
  13. Aslam MI, Hahn VS, Jani V, et al. Reduced right ventricular sarcomere contractility in heart failure with preserved ejection fraction and severe obesity. Circulation. 2021;143:965-7. doi: 10.1161/CIRCULATIONAHA.120.052414
  14. Hahn RT. Tricuspid regurgitation. N Engl J Med. 2023;388:1876-91. doi: 10.1056/NEJMra2216709
  15. Harada T, Obokata M, Omote K. Functional tricuspid regurgitation and right atrial remodeling in heart failure with preserved ejection fraction. Am J Cardiol. 2022;162:129-35. doi: 10.1016/j.amjcard.2021.09.021
  16. Ikoma T, Obokata M, Okada K. Impact of right atrial remodeling in heart right failure with preserved ejection fraction. J Card Fail. 2021;83:897-902. doi: 10.1016/j.cardfail.2020.12.016
  17. Offen S, Playford D, Strange G, et al. Adverse prognostic impact of even mild or moderate tricuspid regurgitation. Am Soc Echocard. 2022;35:810-7. doi: 10.1016/j.echo.2022.04.003
  18. Tung M, Nah G, Marcus G, Delling FN. Valvular diseases burden in modern era of percutaneous and surgical interventions. Open Heart. 2022;9:e002039. doi: 10.1136/openhrt-2022-002039
  19. Mhanna M, Beran A, Al-Abdouh A. AngioVac for vegetation debulking I right sided infective endocarditis. Curr Probl Cardiol. 2022;47:101353. doi: 10.1016/j.cpcardiol.2022.101353
  20. Nguyen A, Schaff HV, Abel MD. Improving outcome of valve replacement for carcinoid heart diseases. J Thorac Cardiovasc Surg. 2019;158:99-107. doi: 10.1016/j.jtcvs.2018.09.025
  21. Bateson B, Ham PB, Patel V, Shah R. Delayed presentation of traumatic tricuspid valve injury during index hospitalization. Am Surg. 2018;84:e67-9.
  22. Muraru D, Addetia K, Guta AC. Right atrium volume is a major determinant of tricuspid annulus area in functional tricuspid regurgitation. Eur Heart J Cardiovasc Imaging. 2021;22:660-9. doi: 10.1093/ehjci/jeaa286
  23. Spinner EM, Lerakis S, Higginson J. Correlates of tricuspid regurgitation as determined by 3D echocardiography: pulmonary arterial pressure, ventricle geometry, annular dilatation, and papillary muscle displacement. Circ Cardiovasc Imaging. 2012;5:43-50. doi: 10.1161/CIRCIMAGING.111.965707
  24. Itelman E, Vatury O, Kuperstein R. The association of severe tricuspid regurgitation with poor survival is modified by right ventricular pressure and function. AM Soc Echocardiogr. 2022;35:1028-36. doi: 10.1016/j.echo.2022.06.012
  25. Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017;18:1342-4. doi: 10.1093/ehjci/jex139
  26. Friedman LS. Congestive hepatopathy. UpToDate. 2023.
  27. Kiernan MS, Udelson JE, Sarnak M. Cardiorenal syndrome: definition, prevalence, diagnosis and pathophysiology. UpToDate. 2023.
  28. Coresh J, Astor BC, Greene T. Prevalence of chronic kidney disease and decreased kidney function in the adult US population. Am J Kidney Dis. 2003;41:1. doi: 10.1053/ajkd.2003.50007
  29. Bock JS, Gotlieb SS. Cardiorenal syndrome: new perspective. Circulation. 2010;121:2592. doi: 10.1161/CIRCULATIONAHA.109.886473
  30. Ronco C, Haapio M, House AA. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:15275. doi: 10.1016/j.jacc.2008.07.051
  31. Smith GL, Lichtman JH, Bracken MB. Renal impairment and outcomes in heart failure. J Am Coll Cardiol. 2006;47:1987. doi: 10.1016/j.jacc.2005.11.084
  32. Aronson D, Mittleman MA, Burger AJ. Elevated blood nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med. 2004;116:466. doi: 10.1016/j.amjmed.2003.11.014
  33. Kataoka H. The “chloride theory”. Med Hypotheses. 2007;1004:170. doi: 10.1016/j.mehy.2017.06.005
  34. Luke RG, Galla JH. It is chloride depletion alkalosis, not contraction alkalosis. J AM Soc Nephrol. 2012;23:204-7. doi: 10.1681/ASN.2011070720
  35. Dupont M, Mullens W, Finucan M. Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail. 2013;15:433-40. doi: 10.1093/eurjhf/hfs209

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies